Company intelligence / Profile preview

Guizhou Yibai Pharmaceutical Co., Ltd.

Guiyang City, Guizhou Province, Chinagzcci.com ↗

Ownership: Private
Employees: ~5509
Development stage: Commercial

Overview

Guizhou Yibai Pharmaceutical is a leading Chinese pharmaceutical company with a diversified portfolio spanning traditional Chinese medicine and modern pharmaceuticals. It has multiple commercialized drugs—such as Aidi Injection for various cancers—and several clinical programs targeting oncology and other indications. The company also operates hospitals and radiotherapy centers across China[1][3][4].

Therapeutic areas: OncologyPulmonologyInfectious DiseasesRheumatologyGastroenterologyCardiovascularWomen's Health
Modalities: Traditional Chinese Medicine (TCM)Small molecule drugsBiologics (including biosimilars and enzymes)Herbal medicines
Industry: Biotech

Drug pipeline

26 assets

aidi injection

25 more assets in the full pipeline.

Beyond the preview

Go deeper on Guizhou Yibai Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guizhou Yibai Pharmaceutical Co., Ltd..